The Effect of Intrathoracic Lesion Location on Initial Tyrosine Kinase Inhibitor Response in Advanced Oncogene-Addicted Non-Small Cell Lung Cancer: A Comparison Between RECIST 1.1 and a Novel Method of Response Assessment (MAX)

Bang, Tami JTami JBangHu, JunxiaoJunxiaoHuPatil, TejasTejasPatilBarón, Anna EAnna EBarónGao, DexiangDexiangGaoCHIH-HSIN YANGHUNG-YANG KUOHSIN-CHIEH HUANGSachs, Peter BPeter BSachsCamidge, D RossD RossCamidge2022-11-072022-11-072022-08-0715257304https://scholars.lib.ntu.edu.tw/handle/123456789/624477Different subtypes of non-small cell lung cancer (NSCLC) are associated with different patterns of metastatic spread. Anatomic location of lesions in the chest may influence patterns of cancer growth and the shrinkage to therapy. Consequently, lesion location could affect apparent response rates per RECIST. We sought to explore this and develop, as needed, treatment response assessments less affected by the location.enLymph node; Parenchymal lung; Pleura; Targeted therapy[SDGs]SDG3The Effect of Intrathoracic Lesion Location on Initial Tyrosine Kinase Inhibitor Response in Advanced Oncogene-Addicted Non-Small Cell Lung Cancer: A Comparison Between RECIST 1.1 and a Novel Method of Response Assessment (MAX)journal article10.1016/j.cllc.2022.08.004361005122-s2.0-85137689837https://api.elsevier.com/content/abstract/scopus_id/85137689837